HIGHLIGHTS
- who: Paul Kupke and collaborators from the Department Germany Hepatitis E University have published the research: Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN- Secretion in the Context of In Vitro Hepatitis E Virus Infection, in the Journal: Cells 2023, 453 of 20/Dec/2022
- what: The authors present results on the immunomodulation of RBV on NK cells in the context of an in_vitro HEV infection and propose a mechanism by which RBV increases IFN-u03b3 production by NK cells. The experiments demonstrate that the addition of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.